Characterization of dystrophic muscle in golden retriever muscular dystrophy dogs by nuclear magnetic resonance imaging

The Golden Retriever Muscular Dystrophy dog lacks dystrophin. Disease progression in this model shares many similarities with the Duchenne muscular dystrophy, both from anatomico pathological and clinical standpoints. The model is increasingly used in pre-clinical trials but needs to be further investigated, particularly with reference to the evaluation of therapies. The aim of this study was to identify quantitative indices that would help characterize the dystrophic dog non-invasively using NMR imaging. Two-month-old dystrophic dogs and healthy control animals were scanned at 4T. Standard T2- and T1-weighted images, fat-saturated T1-weighted images pre- and post-gadolinium chelate injection were acquired and kinetics of muscle enhancement were studied over a 2-h period. Several indices were found to be abnormally high in dystrophic dogs: the T2-weighted/T1-weighted signal ratio, T2-weighted image heterogeneity and maximal signal enhancement post-gadolinium. These may be proposed to evaluate muscle structural alterations non-invasively in this disease.

[1]  Wilbur L. Smith,et al.  Magnetic resonance imaging of children with Duchenne muscular dystrophy , 2006, Pediatric Radiology.

[2]  G. Cossu,et al.  Myogenic stem cells for the therapy of primary myopathies: wishful thinking or therapeutic perspective? , 2000, The Journal of clinical investigation.

[3]  Howard E. Evans,et al.  Miller's anatomy of the dog , 1979 .

[4]  Y. Tateno,et al.  Protron spin‐lattice relaxation time of duchenne dystrophy skeletal muscle by magnetic resonance imaging , 1988, Muscle & nerve.

[5]  E. Engvall,et al.  Canine and feline models of human inherited muscle diseases , 2005, Neuromuscular Disorders.

[6]  S. Majumdar,et al.  Quantitative MR relaxometry study of muscle composition and function in duchenne muscular dystrophy , 1994, Journal of magnetic resonance imaging : JMRI.

[7]  G. Liu,et al.  Duchenne muscular dystrophy: MR grading system with functional correlation. , 1993, Radiology.

[8]  B. Cooper,et al.  Canine X-linked muscular dystrophy: Selective involvement of muscles in neonatal dogs , 1991, Neuromuscular Disorders.

[9]  Luis Garcia,et al.  Rescue of Dystrophic Muscle Through U7 snRNA-Mediated Exon Skipping , 2004, Science.

[10]  J. Kornegay,et al.  Contraction force generated by tarsal joint flexion and extension in dogs with golden retriever muscular dystrophy , 1999, Journal of the Neurological Sciences.

[11]  M. Nishikawa,et al.  Restoration of dystrophin expression in mdx mice by intravascular injection of naked DNA containing full-length dystrophin cDNA , 2004, Gene Therapy.

[12]  Y. Tateno,et al.  Duchenne muscular dystrophy carriers , 1989, Neuroradiology.

[13]  P. Carlier,et al.  Muscle blood flow and oxygenation measured by NMR imaging and spectroscopy , 2006, NMR in biomedicine.

[14]  D. Pennell,et al.  Late gadolinium enhanced cardiovascular magnetic resonance in Becker muscular dystrophy , 2004, Heart.

[15]  R. Mulligan,et al.  Dystrophin expression in the mdx mouse restored by stem cell transplantation , 1999, Nature.

[16]  D. Chang,et al.  Nuclear magnetic resonance study of muscle water protons in muscular dystrophy of chickens , 1981, Journal of cellular physiology.

[17]  W. Ireland.  Miller's Anatomy of the Dog, 3rd ed. , 1995 .

[18]  Peter Hunold,et al.  Myocardial late enhancement in contrast-enhanced cardiac MRI: distinction between infarction scar and non-infarction-related disease. , 2005, AJR. American journal of roentgenology.

[19]  B. Chance,et al.  Canine X‐linked muscular dystrophy studied with in vivo phosphorus magnetic resonance spectroscopy , 1991, Muscle & nerve.

[20]  B. Cooper,et al.  Canine X-linked muscular dystrophy: Morphologic lesions , 1990, Journal of the Neurological Sciences.

[21]  J. Nalbantoglu,et al.  Modulation of Starling forces and muscle fiber maturity permits adenovirus-mediated gene transfer to adult dystrophic (mdx) mice by the intravascular route. , 2000, Human gene therapy.

[22]  A. Emery,et al.  The muscular dystrophies , 2002, The Lancet.

[23]  Walteil J. Murphy,et al.  MRI of normal and pathologic skeletal muscle. , 1986, AJR. American journal of roentgenology.

[24]  F. Nguyen,et al.  Microvessel density in muscles of dogs with golden retriever muscular dystrophy , 2005, Neuromuscular Disorders.

[25]  M. Ladd,et al.  Albumin targeting of damaged muscle fibres in the mdx mouse can be monitored by MRI , 2004, Neuromuscular Disorders.

[26]  J. Dunn,et al.  Quantitative magnetic resonance imaging of the mdx mouse model of Duchenne muscular dystrophy , 1999, Muscle & nerve.

[27]  V. Frouin,et al.  Body composition determined with MR in patients with Duchenne muscular dystrophy, spinal muscular atrophy, and normal subjects. , 1997, Magnetic resonance imaging.

[28]  B. Cooper,et al.  Canine X-linked muscular dystrophy An animal model of Duchenne muscular dystrophy: Clinical studies , 1988, Journal of the Neurological Sciences.

[29]  G. Marsh,et al.  Effects of exercise on muscle transverse relaxation determined by MR imaging and in vivo relaxometry. , 2000, Journal of applied physiology.

[30]  A. Briguet,et al.  Histological parameters for the quantitative assessment of muscular dystrophy in the mdx-mouse , 2004, Neuromuscular Disorders.

[31]  Alfons Verbruggen,et al.  Necrosis-avid contrast agents: introducing nonporphyrin species. , 2002, Academic radiology.

[32]  P. Huang,et al.  Impaired metabolic modulation of alpha-adrenergic vasoconstriction in dystrophin-deficient skeletal muscle. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[33]  R. Bartlett,et al.  An error in dystrophin mRNA processing in golden retriever muscular dystrophy, an animal homologue of Duchenne muscular dystrophy. , 1992, Genomics.